Sofosbuvir and daclatasvir

Br J Clin Pharmacol. 2016 Sep;82(3):878-9. doi: 10.1111/bcp.13011. Epub 2016 Jun 12.
No abstract available

MeSH terms

  • Antiviral Agents / adverse effects
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Carbamates
  • Hepacivirus / drug effects
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Imidazoles / adverse effects
  • Imidazoles / pharmacology*
  • Imidazoles / therapeutic use
  • Pyrrolidines
  • Sofosbuvir / adverse effects
  • Sofosbuvir / pharmacology*
  • Sofosbuvir / therapeutic use
  • Valine / analogs & derivatives

Substances

  • Antiviral Agents
  • Carbamates
  • Imidazoles
  • Pyrrolidines
  • Valine
  • daclatasvir
  • Sofosbuvir